Literature DB >> 18608070

Decisions to participate in research: views of underserved minority drug users with or at risk for HIV.

Jacquelyn Slomka1, Eric A Ratliff, Sheryl A McCurdy, Sandra Timpson, Mark L Williams.   

Abstract

Under-representation of minority populations, particularly African Americans, in HIV/AIDS research is problematic because African Americans bear a greater disease burden from HIV/AIDS. Studies of motivations for participating in research have emphasized factors affecting individuals' willingness to participate and barriers to participation, especially in regard to HIV vaccine research. Little is known about how underserved minority drug users perceive research and their decisions to participate. This study describes African American drug users' perceptions of research participation and their decisions to participate based on three kinds of hypothetical HIV/AIDS-related clinical studies. In-depth, qualitative interviews were conducted with 37 underserved, African American crack cocaine users, recruited from participants already enrolled in three different behavioral HIV prevention studies. Interviews were recorded, transcribed, coded for themes and sub-themes and analyzed using directed and conventional content analysis. Participants' decisions to take part in research often involved multiple motivations for participating. In addition, decisions to participate were characterized by four themes: a desire for information; skepticism and mistrust of research and researchers; perceptions of medical care and monitoring within a study; and participant control in decisions to participate or decline participation. Lack of adequate information and/or medical care and monitoring within a study were related to mistrust, while the provision of information was viewed by some individuals as a right and acknowledgement of the participant's contribution to the study. Participants perceived, rightly or wrongly, that medical monitoring would control some of the risks of a study. Participants also described situations of exerting control over decisions to enter or withdraw from a research study. Preliminary findings suggest that continuous communication and provision of information may enhance enrollment and adherence. Further exploration of decisions to participate in research will add to the understanding of this complex phenomenon and enhance the ability of individuals with HIV/AIDS to benefit from research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608070      PMCID: PMC2873791          DOI: 10.1080/09540120701866992

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  42 in total

1.  Who will enroll? Predicting participation in a phase II AIDS vaccine trial.

Authors:  S D Halpern; D S Metzger; J A Berlin; P A Ubel
Journal:  J Acquir Immune Defic Syndr       Date:  2001-07-01       Impact factor: 3.731

2.  Distrust, race, and research.

Authors:  Giselle Corbie-Smith; Stephen B Thomas; Diane Marie M St George
Journal:  Arch Intern Med       Date:  2002-11-25

3.  The invisible vulnerable: the economically and educationally disadvantaged subjects of clinical research.

Authors:  T Howard Stone
Journal:  J Law Med Ethics       Date:  2003       Impact factor: 1.718

4.  HIV/AIDS among racial/ethnic minority men who have sex with men--United States, 1989-1998.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-01-14       Impact factor: 17.586

5.  Participation in clinical studies among patients infected with HIV-1 in a single treatment centre over 12 years.

Authors:  S Madge; A Mocroft; D Wilson; M Youle; M C Lipman; A Phillips; M Tyrer; A Cozzi-Lepri; L Swaden; M A Johnson
Journal:  HIV Med       Date:  2000-10       Impact factor: 3.180

6.  Racial differences in factors that influence the willingness to participate in medical research studies.

Authors:  Vickie L Shavers; Charles F Lynch; Leon F Burmeister
Journal:  Ann Epidemiol       Date:  2002-05       Impact factor: 3.797

7.  Participation in research and access to experimental treatments by HIV-infected patients.

Authors:  Allen L Gifford; William E Cunningham; Kevin C Heslin; Ron M Andersen; Terry Nakazono; Dale K Lieu; Martin F Shapiro; Samuel A Bozzette
Journal:  N Engl J Med       Date:  2002-05-02       Impact factor: 91.245

8.  Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.

Authors:  R P Strauss; S Sengupta; S Kegeles; E McLellan; D Metzger; S Eyre; F Khanani; C B Emrick; K M MacQueen
Journal:  J Acquir Immune Defic Syndr       Date:  2001-01-01       Impact factor: 3.731

9.  Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials.

Authors:  Anne S Coletti; Patrick Heagerty; Amy R Sheon; Michael Gross; Beryl A Koblin; David S Metzger; George R Seage
Journal:  J Acquir Immune Defic Syndr       Date:  2003-02-01       Impact factor: 3.731

Review 10.  Prospective preference assessment: a method to enhance the ethics and efficiency of randomized controlled trials.

Authors:  Scott D Halpern
Journal:  Control Clin Trials       Date:  2002-06
View more
  19 in total

Review 1.  A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders.

Authors:  Sheba George; Nelida Duran; Keith Norris
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

2.  Perceptions of risk in research participation among underserved minority drug users.

Authors:  Jacquelyn Slomka; Eric A Ratliff; Sheryl McCurdy; Sandra Timpson; Mark L Williams
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

3.  Importance of capacity assessment for an early staged-research network designed to eliminate health disparity: lessons from RTRN.

Authors:  Jae Eun Lee; James Perkins; M Edwina Barnett; Daniel Sarpong; Junghye Sung
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

4.  Risks and benefits of text message-delivered and small group-delivered sexual health interventions among African American women in the Midwestern U.S.

Authors:  Michelle R Broaddus; Lisa A Marsch
Journal:  Ethics Behav       Date:  2015-03

5.  Factors associated with past research participation among low-income persons living with HIV.

Authors:  Jacquelyn Slomka; Georgios Kypriotakis; John Atkinson; Pamela M Diamond; Mark L Williams; Damon J Vidrine; Roberto Andrade; Roberto Arduino
Journal:  AIDS Patient Care STDS       Date:  2012-06-11       Impact factor: 5.078

Review 6.  Ethical issues in mental health research: the case for community engagement.

Authors:  James M Dubois; Brendolyn Bailey-Burch; Dan Bustillos; Jean Campbell; Linda Cottler; Celia B Fisher; Whitney B Hadley; Jinger G Hoop; Laura Roberts; Erica K Salter; Joan E Sieber; Richard D Stevenson
Journal:  Curr Opin Psychiatry       Date:  2011-05       Impact factor: 4.741

7.  Eliminating Racial/Ethnic Disparities in AIDS Clinical Trials in the United States: A Qualitative Exploration of an Efficacious Social/Behavioral Intervention.

Authors:  Amanda Ritchie; Marya Viorst Gwadz; David Perlman; Rebecca De Guzman; Noelle R Leonard; Charles M Cleland
Journal:  J AIDS Clin Res       Date:  2016-12-29

8.  Research Challenges and Bioethics Responsibilities in the Aftermath of the Presidential Apology to the Survivors of the U. S. Public Health Services Syphilis Study at Tuskegee.

Authors:  Vickie M Mays
Journal:  Ethics Behav       Date:  2012

9.  Representation of Latinos and Blacks in screening for and enrollment into preventive HIV vaccine trials in New York City.

Authors:  Tanya M Ellman; Kellie Hawkins; Jorge Benitez; Ramon Negron; Steven Chang; Steven Palmer; Verna Robertson; Mary Ann Chiasson; Magdalena E Sobieszczyk
Journal:  Vaccine       Date:  2015-10-11       Impact factor: 3.641

10.  Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trials.

Authors:  N R Leonard; A Banfield; M Riedel; A S Ritchie; D Mildvan; G Arredondo; C M Cleland; M V Gwadz
Journal:  Health Educ Res       Date:  2013-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.